FDA OKs Injectafer for Iron Deficiency Anemia in HF
The US Food and Drug Administration (FDA) has expanded the indication for ferric carboxymaltose injection (Injectafer, Daiichi Sankyo/American Regent) to include treatment of iron deficiency...
Activities that can cut diabetes risk by three-quarters
Dr Amir lists diabetes symptomsThe finer things in life can actually help you dodge diabetes even if you are genetically vulnerable to it... but not...
Tips to checking your skin for skin cancer
Skin cancer can pop up anywhere on your skin, including the soles of your feet and even under your fingernails. That's what happened to Isabel...
New drug delays progression of glioma, a deadly brain cancer, during clinical trial
In an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend the amount of time people with a...
Neighborhood deprivation and depressive symptoms linked to premature aging
Feeling depressed and living in a deprived urban neighborhood could be making you age faster, according to a new study led by researchers at McMaster...
UNC Health's CIO talks generative AI work with Epic and Microsoft
Photo: UNC Health Brent Lamm is CIO at UNC Health, based in Morrisville, North Carolina. He has quite the seat for the artificial intelligence explosion...
Heart disease risk could be slashed by walking just 20 minutes a day
Heart disease: Doctor explains how to reduce risk in 2021Heart and circulatory diseases are among the biggest killers in the UK, accounting for around a...
New British lung cancer drug from AstraZeneca hailed a 'game changer'
New British lung cancer drug from AstraZeneca is hailed as a 'game changer' that can HALVE the risk of dying The daily tablets target non-small-cell...
American College of Cardiology to host annual Care of the Athletic Heart course
The American College of Cardiology will host the annual Care of the Athletic Heart course on June 8-10, 2023, in Washington, including poster abstracts and...
AstraZeneca to Stop Developing Crohns Disease Drug
(Reuters) - British drugmaker AstraZeneca said on Thursday it would stop developing its drug brazikumab to treat inflammatory bowel diseases, including Crohn's disease and ulcerative...